On March 5, 2018 the Board of Directors of biotechnology company "Human Stem Cells Institute" accepted Artur Isaev's resignation from the CEO's post. It will be replaced by Boguslavsky Dmitry who on is a CEO "The center of genetics and reproductive medicine of "Genetico". Artur Isaev will remain the shareholder of the company and will continue work in Board of Directors.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |